Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VDAC1P3 is one of multiple processed pseudogenes related to the voltage-dependent anion channel 1 (VDAC1) gene in the human genome. It does not encode a functional protein product. Pseudogenes like VDAC1P3 may have minor regulatory effects through non-coding RNA in rare contexts, but VDAC1P3 is expressed at very low levels in a few tissues and has not been implicated in any disease or biological process. The parental gene, VDAC1, encodes a mitochondrial outer membrane channel involved in metabolic regulation and disease, but those functions do not apply to VDAC1P3[2][6][7].\n\nKey points:\n- VDAC1P3 is not a functional protein or drug target.\n- No known biological or disease relevance or biomarker role exists for VDAC1P3 at present.\n- Do not confuse VDAC1P3 with VDAC1, which is a mitochondrial ion channel and a target in multiple diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage dependent anion channel 1 pseudogene 3 (VDAC1P3).